control important cellular functions with direct implications for the onset of diseases such as pulmonary fibrosis or cancer, so these nanozymes could be used in treatments in which the regulation of these metabolites is crucial," explained Carregal.
"The fact that PET can be carried out simultaneously alongside MRI and the fact that the particles themselves demonstrate attenuation ofis a remarkable advance. This had not been seen before. The particles did not normally exert an impact on tumor growth on their own," said Carregal. These promising applications are opening up new avenues for the development of more efficient theranostic agents .
The researcher insisted that"there is still a long way to go. Although we have come up with a more efficient and less costly synthetic process, and we have demonstrated its impact on cell biology, the study of the adjustment mechanisms of the metabolites and long-term biosafety would need to be developed further."
The research group has provided a valuable tool in the field of nanozymes"thanks not only to their catalytic efficiency, but also to their combined use as a multimodal contrast agent. However, there is still a lot of research work to be done until their potential scope is proven in applications that can have an impact on society," concluded Carregal.